Beijing will establish a rapid response system for science and technology in response to emerging infectious diseases

category:Global
 Beijing will establish a rapid response system for science and technology in response to emerging infectious diseases


Green channel for emergency approval application of pharmaceutical innovative products

Measures put forward the establishment of a scientific and technological rapid response system to deal with new outbreaks of infectious diseases. To establish a long-term continuous investment mechanism, aiming at the emerging infectious diseases that threaten the public security and stability of the capital city, in terms of pathogen detection, disease epidemic monitoring and early warning, rapid screening, clinical diagnosis and treatment, convenient killing, research and development and rapid preparation of new drugs (vaccines), application of traditional Chinese medicine, formulation of individual protection standards and development of protection products, emergency health science popularization and psychological intervention, large In terms of data and public health decision support, we will promote Beijing Medical and health institutions, colleges and universities, and innovative enterprises to establish a rapid response system of seamless connection and collaborative innovation.

In terms of the use of biological sample resources, etiology analysis, emergency approval of medical health innovative products, etc., establish the linkage mechanism of relevant departments in the city and strive for the green channel of national authority declaration, support the formulation of relevant clinical diagnosis and treatment and epidemic prevention programs, and the development of rapid diagnostic reagents, killing products and protective equipment, vaccines and new drugs.

The hospital preparation with good effect can be used in the Medical Association

The measures clearly supports the construction of a number of key laboratories in the field of public health and peoples health and other platforms, and supports innovation platforms such as Beijing global health center and global health drug R & D center to play the R & D support capacity of innovative varieties.

We will support medical and health institutions to give priority to the research and development of innovative varieties in key areas, especially the clinical research on the prevention, diagnosis and treatment of new coronavirus infected pneumonia. We will support the use of hospital preparations of high-quality medical institutions with obvious effect in the prevention and control of emerging infectious diseases in the Medical Association.

Accelerate the clinical application and market access of innovative drugs. Actively guide and support innovative drugs to be included in the national basic medical insurance drug catalog; for innovative drugs newly included in the national basic medical insurance catalog and all kinds of new drugs with independent intellectual property rights, filling in clinical gaps and great market potential, open a green channel for drug sunshine procurement, and implement direct online procurement.

Promote traffic and operators to open data to support epidemic analysis

Support Beijing Internet medical related enterprises to participate in the construction of Beijing new coronavirus infection pneumonia online doctor consultation platform, and provide citizens with information release, online consultation, psychological counseling, intelligent guidance, epidemic prediction and other services by using modern information technology.

(function() {(window. Slotbydup = window. Slotbydup| []). Push ({ID: u5811557, container: ssp_, async: true});)) (); promote the appropriate opening of data in transportation, operators, medical and health institutions and other units, support colleges and Universities and enterprises to participate in the construction of Beijing new coronavirus infection pneumonia prevention and control service system, use big data, artificial intelligence and other technologies, sort out and screen the easy To provide support for epidemic analysis, prevention and control, prediction and early warning. Support enterprises and colleges and universities in the field of artificial intelligence in Beijing to carry out the research and development of common key technologies of products such as long-distance large-scale infrared intelligent temperature detector, artificial intelligence triage system, artificial intelligence auxiliary diagnosis products, artificial intelligence drug research and development platform, and promote the demonstration of new technologies and products such as artificial intelligence and big data in the prevention, control and treatment of emerging infectious diseases Fan Yingyong. Beijing News reporter Zhang Lu editor fan Yijing proofread Li Lijun source: Beijing News Editor in charge: Zhao Lixian Gu nag3173

We will promote the appropriate opening of data by transportation, operators, medical and health institutions, and support institutions of higher learning and enterprises to participate in the construction of the Beijing new coronavirus infection pneumonia prevention and control service system. We will use big data, artificial intelligence and other technologies to sort out and screen vulnerable people, and provide support for epidemic analysis, prevention and control, prediction and early warning.

Support enterprises and colleges and universities in the field of artificial intelligence in Beijing to carry out the research and development of common key technologies of products such as long-distance large-scale infrared intelligent temperature detector, artificial intelligence triage system, artificial intelligence auxiliary diagnosis products, artificial intelligence drug research and development platform, and promote the demonstration of new technologies and products such as artificial intelligence and big data in the prevention, control and treatment of emerging infectious diseases Fan Yingyong.

Zhang Lu, reporter of Beijing News

Edited by fan Yijing and proofread by Li Lijun